+34 914 524 941    info@www.algenex.com
 

News

ALGENEX supports development of recombinant biologics with €4m funding round

Spanish biotechnology firm Algenex has progressed to its next stage of development after securing approximately €4 million ($4.5 million) in investment.

Read more